Pharmaceutical Formulations

Omicron (B.1.1.529):  SARS-CoV-2 Variant of Corona Family  The B.1.1.529 variant was first reported from South Africa on 24 November 2021 .  The epidemiological situation in South Africa has been characterized by three distinct   peaks in reported cases, the latest of which was predominantly the Delta variant.  The first known confirmed B.1.1.529 infection was from a specimen collected on 9 November 2021 . This variant has a large number of mutations, some of which are concerning.  Preliminary evidence suggests an increased risk of reinfection with this variant , as compared to other variants of concern (VOCs).  The number of cases of this variant appears to be increasing in almost all provinces in South Africa.  Current SARS-CoV-2 PCR diagnostics continue to detect this variant.  Several labs have indicated that for one widely used PCR test, one of the three target genes is not detected (called S gene dropout or S gene target failure) and ...

  Pharmaceutical formulation  is a process in which different ingredients Active as well as Excipients  are combined to produce a final  medicinal product . The word  formulation  is often used in a way that includes  dosage form .  Medicinal Product can be ALLOPATHIC, AYURVEDIC. HOMEOPATHIC, UNANI, SIDDHA or SPECIAL FOOD to fight, cure, prevent, modify, improve a diseased condition or disease.  There may be combinations of these also like Ayurvedic in Allopathic, Allopathic in Ayurvedic, Allopathic in Food, Ayurvedic in Homeopathic and many other combinations you can check over the counter at CHEMIST SHOP. Final licensing Authority which gives permission to manufacture a medicinal Product determines its class as allopathic, ayurvedic, homeopathic, Unani or Food Product. It also depends upon country to country to put the medicinal product in a particular class depending upon the License granted to manufacture the same.  Every class ...